Evidence map›Paper›PMID 34671740›Full record

ArticleRSC medicinal chemistry2021

Influence of ring size in conformationally restricted ring I analogs of paromomycin on antiribosomal and antibacterial activity.

Michael G Pirrone, Sven N Hobbie, Andrea Vasella, Erik C Böttger, David Crich

Open access · greenAbstract read
In one paragraph

Article in RSC medicinal chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Conformational Properties of ArylThe Journal of organic chemistry · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Michael G PirroneDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia 250 West Green Street Athens GA 30602 USA David.crich@uga.edu.ORCID https://orcid.org/0000-0003-0063-660X
Sven N HobbieInstitute of Medical Microbiology, University of Zurich Gloriastrasse 28 8006 Zürich Switzerland.ORCID https://orcid.org/0000-0002-9205-0384
Andrea VasellaOrganic Chemistry Laboratory, ETH Zürich Vladimir-Prelog-Weg 1-5/10 8093 Zürich Switzerland.
Erik C BöttgerInstitute of Medical Microbiology, University of Zurich Gloriastrasse 28 8006 Zürich Switzerland.
David CrichDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia 250 West Green Street Athens GA 30602 USA David.crich@uga.edu.ORCID https://orcid.org/0000-0003-2400-0083
University of Georgia · USUniversity of Zurich · CHETH Zurich · CH

Funding

Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant DiseasesR01AI123352 · NIAID · WAYNE STATE UNIVERSITY · PI CRICH, DAVID · 2016 to 2019
$2.7M
NIAID NIH HHS R01 AI123352
6 · The paper itself

Abstract

In order to further investigate the importance of the conformation of the ring I side chain in aminoglycoside antibiotic binding to the ribosomal target several derivatives of paromomycin were designed with conformationally locked side chains. By changing the size of the appended ring between O-4' and C-6' used to restrict the motion of the side chain, the position of the C-6' hydroxy group was fine tuned to probe for the optimal conformation for inhibition of the ribosome. While the changes in orientation of the 6'-hydroxy group cannot be completely dissociated from the size and hydrophobicity of the conformation-restricting ring, overall, it is apparent that the preferred conformation of the ring I side chain for interaction with A1408 in the decoding A site of the bacterial ribosome is an ideal

Identifiers

PMID34671740
PMCPMC8459383
OpenAlexW3193262941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.